Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus

Lupus

Volumn 17, Issue 9, 2008, Pages 793-798

  Toloza, S M A ^a   Pellett, F J ^a   Chandran, V ^a   Ibanez, D ^a   Urowitz, M B ^a   Gladman, Dafna D ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Genetic associations; KIR genes; Systemic lupus erythematosus; Vascular arterial events

Indexed keywords

CARDIOLIPIN ANTIBODY; HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS2; UNCLASSIFIED DRUG;

ADULT; ARTERY DISEASE; ARTICLE; CANADA; CONTROLLED STUDY; FEMALE; GENE ACTIVATION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS; ANGINA PECTORIS; BLOOD; CAUCASIAN; COMORBIDITY; GENETICS; HEART INFARCTION; PERIPHERAL VASCULAR DISEASE; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK;

ADULT; ANGINA PECTORIS; ANTIBODIES, ANTICARDIOLIPIN; COMORBIDITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HLA-C ANTIGENS; HUMANS; ISCHEMIC ATTACK, TRANSIENT; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MYOCARDIAL INFARCTION; PERIPHERAL VASCULAR DISEASES; PROSPECTIVE STUDIES; RECEPTORS, KIR; RISK FACTORS; STROKE; VASCULITIS; YOUNG ADULT;

EID: 58949097269     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203308089443     Document Type: Article

References (26)

1. Alarcon-Segovia D Alarcon-Riquelme M. Etiopathogenesis of systemic lupus erythematosus. In: Lahita, RG, (ed), Systemic lupus erythematosus. Academic Press; 2004. p. 93-107.
2. Gladman DD Urowitz MB. In: Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds), Rheumatology. Mosby, St. Louis Mo, USA; 2003. p. 1359-1379.
3. Nikpour M Urowitz MB Gladman DD. Premature atherosclerosis in systemic lupus erythematosus. Rheum Dis Clin North Am 2005; 31: 329-354.
4. Weyand CM Goronzy JJ Liuzzo G. et al. T-cell immunity in acute coronary syndromes. Mayo Clin Proc 2001; 76: 1011-1020.
5. Williams AP Bateman AR Khakoo SI. Hanging in the balance. KIR and their role in disease. Mol Interv 2005; 5: 226-240.
6. Yen JH Moore BE Nakajima T. et al. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med 2001; 193: 1159-1167.
7. Pellett F Siannis F Vukin I Lee P Urowitz M Gladman D. Are KIRs associated with autoimmune disease: Studies in systemic lupus erythematosus and scleroderma. Tissue Antigens 2007; 69(Suppl. 1): 106-108.
8. Urowitz MB Gladman DD. Contributions of observational cohort studies in systemic lupus erythematosus: The University of Toronto lupus clinic experience. Rheum Dis Clin North Am 2005; 31: 211-221.
9. Tan EM Cohen AS Fries JF. et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
10. Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
11. Gladman DD Ibanez D Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29: 288-291.
12. Gladman D Ginzler E Goldsmith C. et al. The development and initial validation of the systemic lupus international collaborating clinics/ American college of rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363-369.
13. Martin MP Nelson G Lee JH. et al. Cutting edge: Susceptibility to psoriatic arthritis: Influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J Immunol 2002; 169: 2818-2822.
14. Bruce IN Urowitz MB Gladman DD Ibanez D Steiner G. Risk factors for coronary heart disease in women with systemic lupus erythematosus: The Toronto risk factor study. Arthritis Rheum 2003; 48: 3159-3167.
15. Hallenbeck JM Hansson GK Becker KJ. Immunology of ischemic vascular disease: Plaque to attack. Trends Immunol 2005; 26: 550-556.
16. Liuzzo G Giubilato G Pinnelli M. T cells and cytokines in atherogenesis. Lupus 2005; 14: 732-735.
17. Esdaile JM Abrahamowicz M Grodzicky T. et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001; 44: 2215-2217.
18. Rahman P Urowitz MB Gladman DD Bruce IN Genest J. Contribution of traditional risk factors to coronary artery disease in patients with SLE. J Rheumatol 1999; 26: 2363-2368.
19. Hsu KC Chida S Geraghty DE Dupont B. The killer cell immunoglobulin-like receptor (KIR) genomic region: Gene-order, haplotypes and allelic polymorphism. Immunol Rev 2002; 190: 40-52.
20. Urowitz MB Ibanez D Gladman DD. Atherosclerotic vascular events in a single large lupus cohort: Prevalence and risk factors. J Rheumatol 2007; 34: 70-75.
21. Brey RL Abbott RD Curb JD. et al. Beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: The Honolulu heart program. Stroke 2001; 32: 1701-1706.
22. Vaarala O. Antiphospholipid antibodies and myocardial infarction. Lupus 1998; 2(Suppl. 7): S132-S134.
23. Lopez LR Dier KJ Lopez D Merrill JT Fink CA. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome. Am J Clin Pathol 2004; 121: 142-149.
24. Mizutani H Kurata Y Kosugi S. et al. Monoclonal anticardiolipin autoantibodies established from the (New Zealand white x BXSB)F1 mouse model of antiphospholipid syndrome cross-react with oxidized low-density lipoprotein. Arthritis Rheum 1995; 38: 1382-1388.
25. Wu R Svenungsson E Gunnarsson I. et al. Antibodies to adult human endothelial cells cross-react with oxidized low-density lipoprotein and beta 2-glycoprotein I (beta 2-GPI) in systemic lupus erythematosus. Clin Exp Immunol 1999; 115: 561-566.
26. Chung CP Oeser A Avalos I. et al. Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis. Arthritis Res Ther 2006; 8: R186.